Abstract:AIM: To clone and characterize novel genes that might be involved in hepatocellular carcinoma. METHODS: An EST fragment differentially expressed between hepatocellular carcinoma (HCC) and its adjacent nontumorous liver tissues had been doned using suppression subtractive hybridization (SSH). With this approach, we identified a novel EST that consisted of 447bp. In order to gain its full-length cDNA fragment, two gene-specific primers were designed for 3′-rapid amplification of cDNA end RACE. One HCC cell line, HepG2, was maintained in the RPMI1640 media and recommended culture conditions. Total RNA was extracted from HepG2 by the SV Total RNA Isolation System (Promega). PACE reactions were prepared using the SMART™ RACE cDNA amplification kit (Clontech). Initial amplification was carried out with gene-specific primer 3′GSP2(5′-CGCATAGT ACCAGTATCGACAA AGG-3′), followed by nested PCR using gene-specific primer 3′NGSP2(5′-TCCACATTACGGACCCGACGGATT- 3′). These amplified cDNA fragments obtained from RACE were subcloned into the PMD18-T vector (TaKaRa) and sequenced by ABI PRISM377 DNA sequencer. Basic local aligment search tools were carried out using BLASTN and dbEST and nr database. Northern blot was applied to detect the expression of these cDNA fragments between HCC and its adjacent nontumorous liver tissues. A total of 3 liver specimens were collected from the Southwest Hospital of Chongqing in China. The final diagnosis of HCC was confirmed by histological examination. Total RNA was extracted from either HCC or its adjacent nontumorous liver tissues in the same way. These cDNA fragments were excised from the PMD18-T vector, purified and 32P-labeled as cDNA probes using the random primed labeling method. Northern blot was prepared by using the ExpressHyb™ hybridization solution (Clontech) according to the protocol provided by the manufacturer. Combination of Northern blot and virtual Northern (http://www.ncbi.nlm.nih.gov/SAGE) (series analysis of gene expression, SAGE), expression of these cDNA fragments in multiple carcinoma and normal tissues were analyzed. RESULTS: Five EST fragments (694 447-3, 724 447-3, 697 447-3, 711 447-3, 692 447-3) were cloned, including two EST fragments with ploy (A) tail (694 447-3, 724 447-3). Compared with ESTs in GeneBank, the two EST fragments with ploy (A) tail represented novel genes with a common sequence. Five EST fragments accession numbers in Genebank were CK730344, CK730345, CK730346, CK730347, CK730348, respectively. Northern blot revealed that 694 447-3, 724 447-3 presented higher expression in HCC than that in its adjacent nontumorous liver tissues. Virtual Northern blot (SAGE) revealed that 694 447-3, 724 447-3 presented higher expression in multiple cancers that contained in brain, colon, breast, lung and stomach than that in their normal tissues. CONCLUSION: Two novel human hepatocellular carcinoma-associated cDNA fragments are identified. RACE technique is a rapid and effective method for seeking for disease related genes in specific tissues.

Identification and Characterization of a Novel Isoform of Hepatopoietin

Isolation and Characterization of a Novel Transcript of Hepatopoietin

Identification of Hepatopoietin Dimerization, Its Interacting Regions and Alternative Splicing of Its Transcription.

Identification and Characterization of Receptor for Mammalian Hepatopoietin That Is Homologous to Yeast ERV1

Primary Study of the Function of a Novel Gene BC047440 Highly Expressed in Human Hepatocellular Carcinoma

Rapid cloning and expression of hepatocellular carcinoma associated cDNA fragments

Hepatopoietin Acts As an Autocrine Growth Factor in Hepatoma Cells

Stimulation of the Mitogen-activated Protein Kinase Cascade and Tyrosine Phosphorylation of the Epidermal Growth Factor Receptor by Hepatopoietin*

Identification of Hepatopoietin Interacting Proteins in Human Testis by Yeast Two-Hybrid System

Biological Function of a Novel Gene Overexpressed in Human Hepatocellular Carcinoma.

Human Hepatic Progenitor Cells Express Hematopoietic Cell Markers Cd45 And Cd109

Molecular cloning and characterization of the promoter of mouse heme-regulated eIF2alpha kinase.

Partial Isolation and Identification of Hepatic Stimulator Substance Mrna Extracted from Human Fetal Liver.

Establishment and Characterization of an Immortalized Human Hepatic Stellate Cell Line for Applications in Co-Culturing with Immortalized Human Hepatocytes

Characterization of the genomic structure and tissue-specific promoter of the human nuclear receptor NR5A2 (hB1F) gene

Studies on Chemicophysical Properties of Recombinant Human Hepatopoietin

[Identification and Characterization of LAPTM4B Encoded by a Human Hepatocellular Carcinoma-Associated Novel Gene].

Identification of a novel human angiopoietin-like gene expressed mainly in heart

The Potentiation Role of Hepatopoietin on Activator Protein-1 is Dependent on Its Sulfhydryl Oxidase Activity

Gene Expression Profiling in Human Fetal Liver and Identification of Tissue- and Developmental-Stage-specific Genes Through Compiled Expression Profiles and Efficient Cloning of Full-Length Cdnas.

Cloning of Ap1 Coactivator Jab1 and Its Association with Hepatopoietin